The management and treatment of prostate cancer is evolving to address unmet patient needs, with advancements spanning from diagnosis to advanced disease. A symposium at the Global Congress on Prostate Cancer (PROSCA) 2024 brought together experts to discuss recent treatment developments, clinical implications, and the need for collaboration to address global disparities in prostate cancer mortality.
EMJ Urology 13 [Supplement 1] . 2025
March 2025
Latest articles
All articles
4 Mins
15th
April
Post-partum Urinary Retention: Under-recognised, Under-treated
Pain, increased bleeding, nerve damage, and, at worst, bladder rupture are a few of the potential consequences of undertreated post-partum…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
4 Mins
4th
March
Leiomyosarcoma in Post-Embolised Angiomyolipoma
Sarcomatous transformation of the angiomyolipoma (AML) is a rare event with a handful of cases reported in the literature.¹ It is marked by…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
3 Mins
17th
February
Advancing Neurological Urology: Marcus Drake
EMJ is pleased to welcome Marcus Drake, Professor of Neurological Urology at Imperial College London, UK, who shared insights into the…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
8 Mins
20th
December
Unravelling Prostate Cancer Treatments: Axel Heidenreich
EMJ is delighted to introduce Axel Heidenreich, Professor and Director at the University of Cologne, Germany, who spoke to us about…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.